EGFR and neoplasm: For example, endothelial growth factor receptor (EGFR) is overexpressed in many types of tumors and has been frequently used as a target in tumor imaging; monoclonal antibodies targeting EGFR such as cetuximab, bevacizumab, and panitumumab have been approved for clinical applications.